BACKGROUND: This study was aimed at estimating the human papillomavirus (HPV) prevalence and its determinants among a sample of Ghanaian women. DESIGN: Cross-sectional observational study. SETTING: Gynaecology outpatient clinic of the Korle-Bu Teaching Hospital, Accra, Ghana; the largest tertiary care gynaecology outpatient clinic in Ghana. PARTICIPANTS: Convenient sample of 75 consenting women visiting the clinic. METHODS: Information was obtained through personal interviews using structured questionnaire, Pap smears obtained, and laboratory testing of cervical exfoliated cells was performed. HPV DNA was detected using a GP5+/6+ polymerase chain reaction assay. These data were analyzed using both univariate and bivariate techniques. RESULTS: The mean age of participants was 33.3 years (standard deviation, 9.2) and the percentage of lifetime monogamy was 21.3%. The crude HPV DNA prevalence was 10.7%. Unlike most populations studied so far, HPV prevalence was high not only among young women, but also in middle and old age. Independent HPV determinants were being illiterate (prevalence odds ratio [POR], 13.9; 95% confidence interval [95%CI], 1.9-100) and reporting more than three lifetime sexual partners (POR, 4.6; 95% CI, 1.0-22.2). CONCLUSIONS: The study indicates a high crude prevalence of HPV in a largely polygamous Ghanaian population with a high crude prevalence in older age groups, which may be a distinctive feature of polygamous populations where HPV transmission continues into middle age and cervical cancer incidence is very high.
BACKGROUND: This study was aimed at estimating the human papillomavirus (HPV) prevalence and its determinants among a sample of Ghanaian women. DESIGN: Cross-sectional observational study. SETTING: Gynaecology outpatient clinic of the Korle-Bu Teaching Hospital, Accra, Ghana; the largest tertiary care gynaecology outpatient clinic in Ghana. PARTICIPANTS: Convenient sample of 75 consenting women visiting the clinic. METHODS: Information was obtained through personal interviews using structured questionnaire, Pap smears obtained, and laboratory testing of cervical exfoliated cells was performed. HPV DNA was detected using a GP5+/6+ polymerase chain reaction assay. These data were analyzed using both univariate and bivariate techniques. RESULTS: The mean age of participants was 33.3 years (standard deviation, 9.2) and the percentage of lifetime monogamy was 21.3%. The crude HPV DNA prevalence was 10.7%. Unlike most populations studied so far, HPV prevalence was high not only among young women, but also in middle and old age. Independent HPV determinants were being illiterate (prevalence odds ratio [POR], 13.9; 95% confidence interval [95%CI], 1.9-100) and reporting more than three lifetime sexual partners (POR, 4.6; 95% CI, 1.0-22.2). CONCLUSIONS: The study indicates a high crude prevalence of HPV in a largely polygamous Ghanaian population with a high crude prevalence in older age groups, which may be a distinctive feature of polygamous populations where HPV transmission continues into middle age and cervical cancer incidence is very high.
Authors: Patti E Gravitt; Anant M Kamath; Lynne Gaffikin; Z Michael Chirenje; Sharita Womack; Keerti V Shah Journal: Int J Cancer Date: 2002-08-20 Impact factor: 7.396
Authors: S D Womack; Z M Chirenje; L Gaffikin; P D Blumenthal; J A McGrath; T Chipato; S Ngwalle; M Munjoma; K V Shah Journal: Int J Cancer Date: 2000-01-15 Impact factor: 7.396
Authors: P Mayaud; D K Gill; H A Weiss; E Uledi; L Kopwe; J Todd; G ka-Gina; H Grosskurth; R J Hayes; D C Mabey; C J Lacey Journal: Sex Transm Infect Date: 2001-08 Impact factor: 3.519
Authors: X Castellsagué; C Menéndez; M P Loscertales; J R Kornegay; F dos Santos; F X Gómez-Olivé; B Lloveras; N Abarca; N Vaz; A Barreto; F X Bosch; P Alonso Journal: Lancet Date: 2001-10-27 Impact factor: 79.321
Authors: Silvia Franceschi; Thangarajan Rajkumar; Salvatore Vaccarella; Vendhan Gajalakshmi; Ajit Sharmila; Peter J F Snijders; Nubia Muñoz; Chris J L M Meijer; Rolando Herrero Journal: Int J Cancer Date: 2003-10-20 Impact factor: 7.396
Authors: J O Thomas; R Herrero; A A Omigbodun; K Ojemakinde; I O Ajayi; A Fawole; O Oladepo; J S Smith; A Arslan; N Muñoz; P J F Snijders; C J L M Meijer; S Franceschi Journal: Br J Cancer Date: 2004-02-09 Impact factor: 7.640
Authors: M Molano; H Posso; E Weiderpass; A J C van den Brule; M Ronderos; S Franceschi; C J L M Meijer; A Arslan; N Munoz Journal: Br J Cancer Date: 2002-07-29 Impact factor: 7.640
Authors: Cecily Banura; Florence M Mirembe; Jackson Orem; Anthony K Mbonye; Simon Kasasa; Edward K Mbidde Journal: Infect Agent Cancer Date: 2013-07-10 Impact factor: 2.965
Authors: Yvonne Nartey; Philip Hill; Kwabena Amo-Antwi; Richard Asmah; Kofi Nyarko; Joel Yarney; Nelson Damale; Brian Cox Journal: Ghana Med J Date: 2018-06
Authors: Dennis O Laryea; Baffour Awuah; Yaw A Amoako; E Osei-Bonsu; Joslin Dogbe; Rita Larsen-Reindorf; Daniel Ansong; Kwasi Yeboah-Awudzi; Joseph K Oppong; Thomas O Konney; Kwame O Boadu; Samuel B Nguah; Nicholas A Titiloye; Nicholas O Frimpong; Fred K Awittor; Iman K Martin Journal: BMC Cancer Date: 2014-05-23 Impact factor: 4.430